pubmed-article:15023167 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C1708335 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0358591 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0937846 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0018517 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0439590 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0442113 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
pubmed-article:15023167 | lifeskim:mentions | umls-concept:C1455363 | lld:lifeskim |
pubmed-article:15023167 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:15023167 | pubmed:dateCreated | 2004-3-16 | lld:pubmed |
pubmed-article:15023167 | pubmed:abstractText | Proton pump inhibitors control gastric acidity better during the day than at night, when nocturnal acid breakthrough can occur. Tenatoprazole is a novel proton pump inhibitor with a seven-fold longer plasma half-life. Aim : To compare the effects of tenatoprazole 20 mg (T20), tenatoprazole 40 mg (T40) and esomeprazole 40 mg (E40) on intragastric acidity in healthy volunteers. | lld:pubmed |
pubmed-article:15023167 | pubmed:language | eng | lld:pubmed |
pubmed-article:15023167 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15023167 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15023167 | pubmed:month | Mar | lld:pubmed |
pubmed-article:15023167 | pubmed:issn | 0269-2813 | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:GalmicheJ PJP | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:FiorentiniPP | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:Bruley Des... | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:HomerinMM | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:DucrottéPP | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:TaccoenAA | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:VavasseurFF | lld:pubmed |
pubmed-article:15023167 | pubmed:author | pubmed-author:Sacher-Huveli... | lld:pubmed |
pubmed-article:15023167 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15023167 | pubmed:day | 15 | lld:pubmed |
pubmed-article:15023167 | pubmed:volume | 19 | lld:pubmed |
pubmed-article:15023167 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15023167 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15023167 | pubmed:pagination | 655-62 | lld:pubmed |
pubmed-article:15023167 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:meshHeading | pubmed-meshheading:15023167... | lld:pubmed |
pubmed-article:15023167 | pubmed:year | 2004 | lld:pubmed |
pubmed-article:15023167 | pubmed:articleTitle | Tenatoprazole, a novel proton pump inhibitor with a prolonged plasma half-life: effects on intragastric pH and comparison with esomeprazole in healthy volunteers. | lld:pubmed |
pubmed-article:15023167 | pubmed:affiliation | CIC-INSERM, CHU de Nantes, Nantes, France. galmiche@easynet.fr | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15023167 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023167 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15023167 | lld:pubmed |